4,573 articles in this topic
A new AI-powered platform combines genetics, hormones, and lifestyle data to assess 130+ female-specific conditions before they worsen.
Boston biotech Anodyne Nanotech secures Series A funding to advance a once-weekly GLP-1 obesity patch into first human trials.
FDA Breakthrough Designation for fosigotifator validates the Integrated Stress Response as a real therapeutic target in neurodegeneration and aging.
A overlooked odd-chain fatty acid called C15 is challenging decades of blanket anti-fat dietary advice and attracting longevity researchers.
Mice lacking HDAC11 reach old age with less muscle wasting, stronger fibers, better fatty acid profiles, and zero premature deaths.
The FAXAge trial will test time-restricted feeding and exercise on DNA methylation age in 240 adults over 65 — with a 10-year follow-up.
A new review maps how blood stem cell metabolism shifts with aging and how leukemia hijacks those changes — pointing to targeted therapeutic strategies.
A new review traces how aging science evolved from single-cause theories to partial reprogramming with Yamanaka factors as a lifespan-extending strategy.
A massive European study shows proteomic age clocks rival lifestyle risk factors in predicting mortality and chronic disease.
EGCG, the key polyphenol in green tea, inhibits fibroid growth and may offer a safe, non-invasive alternative to surgery for uterine myomas.
A 2025 comprehensive review maps EGCG's mechanisms across oncology, dermatology, neuroprotection, and metabolic disease.
A 2025 review maps the inflammatory pathways driving chronic endometritis and evaluates antibiotics, intrauterine therapy, and probiotics as treatments.
